Alprazolam

Niravam, Xanax (alprazolam) is a small molecule pharmaceutical. Alprazolam was first approved as Niravam on 1982-01-01. It is used to treat agoraphobia, depressive disorder, and panic disorder in the USA. It is known to target gamma-aminobutyric acid receptor subunit alpha-3, gamma-aminobutyric acid receptor subunit alpha-5, gamma-aminobutyric acid receptor subunit alpha-1, gamma-aminobutyric acid receptor subunit alpha-2, and bromodomain-containing protein 4.